Error: Could not add to watchlist. X

Algeta ASA

+ Watchlist
ALGETA:SS
Acquired
ALGETA:SS was acquired by BAYN:GR
NOK
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (NOK) (TTM)
-
Market Cap (NOK)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
Profile
Algeta ASA operates in the pharmaceutical industry. The Company develops targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. Algeta's compound Alpharadin is designed to treat bone metastases.
ADDRESS
PO Box 54 Kjelsas
Oslo, 0884
Norway
PHONE
47-23-00-79-90
  • Thomas Ramdahl
    Managing Director
  • Roger Harrison
    Chief Business Officer
  • Gillies O'Bryan Tear
    Chief Medical Officer
  • Andreas Menrad
    Chief Scientific Officer
  • Kari Gronas Dyvik
    Senior VP:Operations
Show More